CW Advisors LLC Has $12.99 Million Stake in UnitedHealth Group Incorporated $UNH

CW Advisors LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 33.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 41,639 shares of the healthcare conglomerate’s stock after buying an additional 10,503 shares during the period. CW Advisors LLC’s holdings in UnitedHealth Group were worth $12,991,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Caitlin John LLC lifted its stake in UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock worth $451,000 after purchasing an additional 111 shares during the period. Murphy Pohlad Asset Management LLC lifted its position in shares of UnitedHealth Group by 21.8% during the 2nd quarter. Murphy Pohlad Asset Management LLC now owns 4,425 shares of the healthcare conglomerate’s stock worth $1,380,000 after buying an additional 791 shares during the period. Triumph Capital Management bought a new stake in UnitedHealth Group in the second quarter valued at $1,324,000. Wealth Effects LLC grew its position in UnitedHealth Group by 14.4% during the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after acquiring an additional 591 shares during the last quarter. Finally, Towercrest Capital Management bought a new stake in shares of UnitedHealth Group during the second quarter worth $236,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 4.8%

Shares of UNH opened at $340.13 on Thursday. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $308.10 billion, a PE ratio of 17.75, a P/E/G ratio of 2.11 and a beta of 0.43. The firm’s 50 day moving average is $342.30 and its 200-day moving average is $315.70. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $622.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company’s revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the company earned $7.15 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Mizuho increased their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. KeyCorp boosted their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Royal Bank Of Canada lifted their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Piper Sandler cut their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a report on Tuesday, October 28th. Finally, Deutsche Bank Aktiengesellschaft cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a report on Wednesday, October 29th. Eighteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.